Tillman Gerngross, Repligen

Till­man Gern­gross project out of Dart­mouth Col­lege ac­quired by Repli­gen

Hot off of his biotech uni­corn land­ing on the Nas­daq, an­oth­er project from the lab of Dart­mouth Col­lege en­gi­neer­ing pro­fes­sor Till­man Gern­gross has made news, as it’s been ac­quired by Repli­gen.

Avi­tide will now be owned by Repli­gen, the com­pa­ny an­nounced last Thurs­day, in a move made to boost its pro­teins busi­ness.

The deal moves Repli­gen in­to the world of affin­i­ty resin pu­rifi­ca­tion for gene ther­a­py, and com­ple­ments an es­tab­lished part­ner­ship with Nav­i­go GmbH, the com­pa­ny said in the press re­lease. Avi­tide de­vel­ops pu­rifi­ca­tion tech­nol­o­gy for pro­grams rang­ing from pre­clin­i­cal to com­mer­cial prod­ucts. Ear­li­er this month, Navio and Repli­gen col­lab­o­rat­ed to de­vel­op a lig­and that helps over­come chal­lenges as­so­ci­at­ed with the pu­rifi­ca­tion of pH sen­si­tive an­ti­bod­ies.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.